Abstract
A technique is described for estimating the biliary excretion, reabsorption and re-excretion of an antibacterial drug in rats. D(—)-6-(α-Amino-α-phenylacetamido)-penicillanic acid (BRL 1341) is rapidly excreted and re-excreted in the bile, in concentrations bactericidal to Salmonellae and other organisms which are usually refractory to antibacterial drugs in this situation. Recoveries of the drug accounted for 20 to 30% of oral of parenteral doses; much of the remainder is probably destroyed in the gut. Results from one patient indicate that D(—)-6-(α-amino-α-phenylacetamido)-penicillanic acid is excreted in high concentration also in human bile.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ROLINSON G. N., STEVENS S. Microbiological studies on a new broad-spectrum penicilin, "Penbritin". Br Med J. 1961 Jul 22;2(5246):191–196. doi: 10.1136/bmj.2.5246.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- STEWART G. T. Microbiological studies on sodium 6-(2, 6 dimethoxybenzamido) penicillanate monohydrate (BRL 1241) in vitro and in patients. Br Med J. 1960 Sep 3;2(5200):694–699. doi: 10.1136/bmj.2.5200.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stewart G. T., Coles H. M., Nixon H. H., Holt R. J. "Penbritin": An Oral Penicillin with Broad-spectrum Activity. Br Med J. 1961 Jul 22;2(5246):200–206. doi: 10.1136/bmj.2.5246.200. [DOI] [PMC free article] [PubMed] [Google Scholar]